Excellent long-term outcome for survivors of apple peel atresia

S Festen1, J C Brevoord, G A Goldhoorn

  • 1Amsterdam, Nijmegen, Rotterdam, Maastricht, Groningen, and Utrecht, The Netherlands.

Insights

Apple peel atresia, a rare condition, presents significant early risks but shows low long-term morbidity. Children surviving the critical period often achieve normal growth and development with good bowel function.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Neonatal Care

Background:

  • Apple peel atresia is an exceptionally rare form of small bowel atresia.
  • Its rarity and high mortality rate limit understanding of long-term outcomes.

Purpose of the Study:

  • To investigate the long-term outcomes for children diagnosed with apple peel atresia.

Main Methods:

  • Retrospective review of 15 patient charts, operative reports, and office notes from six Dutch pediatric surgical centers.
  • Long-term follow-up data obtained through office note review and patient questionnaires.

Main Results:

  • The median age at operation was 1.5 days.
  • Postoperative complications included cholestasis (53%) and sepsis (40%); 20% of patients died.
  • At a median follow-up of 24 months, most children experienced normal growth and development, though some had short bowel syndrome or growth retardation initially.

Conclusions:

  • Despite significant short-term morbidity (e.g., short bowel syndrome, sepsis), long-term morbidity in apple peel atresia is low.
  • Survival through the operative and immediate postoperative periods, managing malnutrition and total parenteral nutrition, leads to a good prognosis for normal bowel function, growth, and development.
Abstract

Related Concept Videos